Search by Drug Name or NDC

    NDC 65162-0207-03 Oxycodone and Acetaminophen 325; 7.5 mg/1; mg/1 Details

    Oxycodone and Acetaminophen 325; 7.5 mg/1; mg/1

    Oxycodone and Acetaminophen is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE.

    Product Information

    NDC 65162-0207
    Product ID 65162-207_2dbd07c9-bc06-4337-a49e-08c551aa61f0
    Associated GPIs 65990002200327
    GCN Sequence Number 048976
    GCN Sequence Number Description oxycodone HCl/acetaminophen TABLET 7.5-325 MG ORAL
    HIC3 H3U
    HIC3 Description OPIOID ANALGESIC AND NON-SALICYLATE ANALGESICS
    GCN 14965
    HICL Sequence Number 001741
    HICL Sequence Number Description OXYCODONE HCL/ACETAMINOPHEN
    Brand/Generic Generic
    Proprietary Name Oxycodone and Acetaminophen
    Proprietary Name Suffix n/a
    Non-Proprietary Name Oxycodone and Acetaminophen
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 325; 7.5
    Active Ingredient Units mg/1; mg/1
    Substance Name ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
    Labeler Name Amneal Pharmaceuticals LLC
    Pharmaceutical Class Full Opioid Agonists [MoA], Opioid Agonist [EPC]
    DEA Schedule CII
    Marketing Category ANDA
    Application Number ANDA040778
    Listing Certified Through 2023-12-31

    Package

    NDC 65162-0207-03 (65162020703)

    NDC Package Code 65162-207-03
    Billing NDC 65162020703
    Package 30 TABLET in 1 BOTTLE (65162-207-03)
    Marketing Start Date 2013-11-01
    NDC Exclude Flag N
    Pricing Information N/A